ORBIMED ADVISORS LLC 13D and 13G filings for Protara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 7:11 pm Sale |
2023-12-31 | 13G | Protara Therapeutics, Inc. TARA |
ORBIMED ADVISORS LLC | 0 0.000% |
-671,741 (Position Closed) |
Filing |
| 2023-02-14 4:52 pm Unchanged |
2022-12-31 | 13G | Protara Therapeutics, Inc. TARA |
ORBIMED ADVISORS LLC | 671,741 6.000% |
0 (Unchanged) |
Filing |
| 2022-02-11 4:40 pm Purchase |
2021-12-31 | 13G | Protara Therapeutics, Inc. TARA |
ORBIMED ADVISORS LLC | 671,741 6.000% |
671,741 (New Position) |
Filing |